|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 98.84 USD | -1.21% |
|
-2.06% | +0.07% |
| 12/02 | Pharma companies left out of Trump's drug-pricing deals look for way in | RE |
| 11/02 | Pharma companies left out of Trump's drug-pricing deals look for way in | RE |
| Capitalization | 1.96TCr 1.65TCr 1.51TCr 1.44TCr 2.67TCr 1,78200Cr 2.76TCr 17TCr 6.97TCr 86TCr 7.37TCr 7.21TCr 3,00600Cr | P/E ratio 2025 |
15.4x | P/E ratio 2026 * | 15x |
|---|---|---|---|---|---|
| Enterprise value | 1.56TCr 1.32TCr 1.21TCr 1.15TCr 2.12TCr 1,41900Cr 2.2TCr 14TCr 5.55TCr 68TCr 5.87TCr 5.75TCr 2,39500Cr | EV / Sales 2025 |
3.17x | EV / Sales 2026 * | 2.52x |
| Free-Float |
97.51% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Incyte Corporation
| 1 day | -1.21% | ||
| 1 week | -2.06% | ||
| Current month | -1.23% | ||
| 1 month | -7.51% | ||
| 3 months | -6.74% | ||
| 6 months | +26.09% | ||
| Current year | +0.07% |
| 1 week | 97.25 |  | 109.48 |
| 1 month | 97.25 | | 109.48 |
| Current year | 97.25 | | 112.29 |
| 1 year | 53.56 | | 112.29 |
| 3 years | 50.27 | | 112.29 |
| 5 years | 50.27 | | 112.29 |
| 10 years | 50.27 | | 153.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Meury
CEO | Chief Executive Officer | 58 | 26/06/2025 |
Thomas Tray
DFI | Director of Finance/CFO | 49 | 16/09/2025 |
Pablo Cagnoni
PSD | President | 62 | 05/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baker
CHM | Chairman | 59 | 26/06/2025 |
| Director/Board Member | 72 | 20/01/2015 | |
Paul Clancy
BRD | Director/Board Member | 64 | 20/01/2015 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -3.27% | 14.55% | 253 M€ | |
| 0.00% | 2.94% | 1 M€ | |
| -3.76% | 2.88% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.21% | -2.06% | +44.71% | +24.70% | 1.96TCr | |
| +3.19% | +2.61% | +12.84% | +2.82% | 7.75TCr | |
| -4.64% | -8.24% | -39.54% | -46.41% | 5.84TCr | |
| -0.38% | +1.15% | +38.08% | +233.92% | 5.99TCr | |
| +0.12% | +71.20% | +71.20% | +71.20% | 5.44TCr | |
| +1.17% | +8.17% | +34.14% | -33.22% | 2.77TCr | |
| 0.00% | +13.77% | +146.63% | +109.46% | 1.99TCr | |
| -3.54% | -4.00% | +27.11% | -76.07% | 1.64TCr | |
| +2.10% | +14.41% | +27.17% | +67.02% | 1.55TCr | |
| +1.85% | -4.47% | -1.79% | +850.62% | 1.39TCr | |
| Average | -0.13% | +4.11% | +36.05% | +120.41% | 3.63TCr | |
| Weighted average by Cap. | -0.09% | +1.94% | +28.69% | +79.12% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 497.97Cr 419.4Cr 383.88Cr 365.5Cr 675.74Cr 45TCr 699.09Cr 4.43TCr 1.77TCr 22TCr 1.87TCr 1.83TCr 76TCr | 561.19Cr 472.65Cr 432.62Cr 411.91Cr 761.54Cr 51TCr 787.85Cr 4.99TCr 1.99TCr 24TCr 2.1TCr 2.06TCr 86TCr |
| Net income | 127.29Cr 107.2Cr 98Cr 93Cr 172.73Cr 12TCr 178.69Cr 1.13TCr 451.48Cr 5.55TCr 477.34Cr 467.49Cr 19TCr | 138.37Cr 116.53Cr 106.67Cr 101.56Cr 187.76Cr 13TCr 194.25Cr 1.23TCr 490.79Cr 6.04TCr 518.9Cr 508.19Cr 21TCr |
| Net Debt | -399.52Cr -336.48Cr -307.99Cr -293.24Cr -542.15Cr -36TCr -560.88Cr -3.55TCr -1.42TCr -17TCr -1.5TCr -1.47TCr -61TCr | -549.47Cr -462.77Cr -423.59Cr -403.3Cr -745.63Cr -50TCr -771.39Cr -4.89TCr -1.95TCr -24TCr -2.06TCr -2.02TCr -84TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | 98.84 $ | -1.21% | 19,06,875 |
| 10/26/10 | 100.05 $ | -8.24% | 47,48,829 |
| 09/26/09 | 109.03 $ | +0.59% | 27,00,690 |
| 06/26/06 | 108.39 $ | +5.48% | 21,93,912 |
| 05/26/05 | 102.76 $ | +0.16% | 20,47,491 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- INCY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition